-
公开(公告)号:WO2004074266A8
公开(公告)日:2004-11-11
申请号:PCT/EP2004050084
申请日:2004-02-05
Applicant: JANSSEN PHARMACEUTICA NV , LEWI PAULUS JOANNES , ARTS THEODORA JOANNA FRANCISCA , JANSSEN GRAZIELLA MARIA CONSTA , JANSSEN HERWIG JOSEPHUS MARGAR , JANSSEN JASMINE JOSEE WERNER H , JANSSEN PAUL PETER MARIA HM , JANSSEN MAROUSSIA GODELIEVE FR , DE JONGE MARC RENE , KOYMANS LUCIEN MARIA HENRICUS , VINKERS HENDRIK MAARTEN , DAEYAERT FREDERIK FRANS DESIRE , HEERES JAN , LEENDERS RUBEN GERARDUS GEORGE , HOORNAERT GEORGES JOSEPH CORNE , KILONDA AMURI , LUDOVICI DONALD WILLIAM
Inventor: LEWI PAULUS JOANNES , JANSSEN PAUL ADRIAAN JAN DI , DE JONGE MARC RENE , KOYMANS LUCIEN MARIA HENRICUS , VINKERS HENDRIK MAARTEN , DAEYAERT FREDERIK FRANS DESIRE , HEERES JAN , LEENDERS RUBEN GERARDUS GEORGE , HOORNAERT GEORGES JOSEPH CORNE , KILONDA AMURI , LUDOVICI DONALD WILLIAM
IPC: A61K31/53 , C07D253/06 , C07D253/07 , C07D253/075
CPC classification number: A61K31/53 , C07D253/07 , C07D253/075
Abstract: The present invention relates to HIV replication inhibitors of formula (I) as defined in the specification their use as a medicine, their processes for preparation and pharmaceutical compositions comprising them.
Abstract translation: 本发明涉及如说明书中所定义的式(I)的HIV复制抑制剂作为药物的用途,它们的制备方法和包含它们的药物组合物。
-
公开(公告)号:AU2005271161B2
公开(公告)日:2011-05-12
申请号:AU2005271161
申请日:2005-08-10
Applicant: JANSSEN PHARMACEUTICA NV
Inventor: JONGE MARC RENE DE , VINKERS HENDRIK MAARTEN , KILONDA AMURI , HEERES JAN , HOORNAERT GEORGES JOSEPH CORNELIUS , JANSSEN PAUL ADRIAAN JAN , LEWI PAULUS JOANNES , KOYMANS LUCIEN MARIA HENRICUS , DAEYAERT FREDERIK FRANS DESIRE
IPC: C07D253/06 , A61K31/53 , A61P31/18
Abstract: The present invention relates to HIV replication inhibitors of formula a N-oxide, a pharmaceutically acceptable addition salt, a quaternary amine or a stereochemically isomeric form thereof, wherein ring A and ring B represent phenyl, pyridyl, pyridazinyl, pyrimidinyl or pyrazinyl; n and m are 1 to 4; R1 represents hydrogen; aryl; formyl; C1-6alkylcarbonyl; C1-6alkyloxycarbonyl; optionally substituted C1-6alkyl; C1-6alkyloxyC1-6alkylcarbonyl substituted with C1-6alkyloxycarbonyl; R2 or R4 represents hydrogen; hydroxy; halo; optionally substituted C1-6alkyl; optionally substituted C2-6alkenyl; optionally substituted C2-6alkynyl; C3-7cycloalkyl; C1-6alkyloxy; C1-6alkyloxycarbonyl; C1-6alkylcarbonyloxy; carboxyl; cyano; nitro; amino; mono- or di(C1-6alkyl)amino; polyhaloC1-4alkyl; polyhaloC1-4alkyloxy; polyhaloC1-4alkylthio; —S(═O)pR6; —NH—S(═O)pR6; —C(═O)R6; —NHC(═O)H; —C(═O)NHNH2; NHC(═O)R6; C(═NH)R6; or R7; R2a or R3 represents cyano; aminocarbonyl; amino; halo; NHR13; NR13R14; —C(═O)—NHR13; —C(═O)—NR13R14; —C(═O)—R15; —CH═N—NH—C(═O)—R16; optionally substituted C1-6alkyl; optionally substituted C1-6alkyloxy; optionally substituted C1-6alkyloxyC1-6alkyl; optionally substituted C2-6alkenyl; optionally substituted C2-6alkynyl; —C(═N—O—R8)—C1-4alkyl; R7 or —X3—R7; X1 or X2 represents —NR1—; —NH—NH—; —N═N—; —O—; —C(═O)—; —C1-4alkanediyl-; —CHOH—; —S—; —S(═O)p—; —X4—C1-4alkanediyl-; —C1-4alkanediyl-X4—; or —C1-4alkanediyl-X4—C1-4alkanediyl-; their use as a medicine, their use for the manufacture of a medicament for the treatment or the prevention of HIV infection; their processes for preparation and pharmaceutical compositions comprising them.
-
公开(公告)号:CA2437785C
公开(公告)日:2009-05-12
申请号:CA2437785
申请日:2002-03-13
Applicant: JANSSEN PHARMACEUTICA NV
Inventor: KOYMANS LUCIEN MARIA HENRICUS , DE JONGE MARC RENE , HEERES JAN , DAEYAERT FREDERIK FRANS DESIRE , COMPERNOLLE FRANS JOSEF CORNELIUS , HOORNAERT GEORGES JOSEPH CORNELIUS , VAN AKEN KOEN JEANNE ALFONS , JANSSEN PAUL ADRIAAN JAN , KILONDA AMURI , LEWI PAULUS JOANNES
IPC: C07D241/20 , A61K31/4965 , A61P31/18
Abstract: This invention concerns compounds of formula (I) (see formula I) a N-oxide, a pharmaceutically acceptable addition salt, or a stereochemicall y isomeric form thereof; their use as a medicine for inhibiting HIV replicatio n, their processes for preparation and pharmaceutical compositions comprising them.
-
公开(公告)号:AT367814T
公开(公告)日:2007-08-15
申请号:AT02740421
申请日:2002-03-13
Applicant: JANSSEN PHARMACEUTICA NV
Inventor: JANSSEN PAUL , VAN AKEN KOEN , LEWI PAULUS , KOYMANS LUCIEN , DE JONGE MARC , HEERES JAN , DAEYAERT FREDERIK , HOORNAERT GEORGES , COMPERNOLLE FRANS , KILONDA AMURI
IPC: A61K31/4965 , A61P31/18 , C07D241/20
-
公开(公告)号:CA2575002A1
公开(公告)日:2006-02-16
申请号:CA2575002
申请日:2005-08-10
Applicant: JANSSEN PHARMACEUTICA NV
Inventor: DAEYAERT FREDERIK FRANS DESIRE , DE JONGE MARC RENE , HEERES JAN , LEWI PAULUS JOANNES , KOYMANS LUCIEN MARIA HENRICUS , VINKERS HENDRIK MAARTEN , KILONDA AMURI , HOORNAERT GEORGES JOSEPH CORNE , JANSSEN PAUL ADRIAAN JAN
IPC: C07D253/06 , A61K31/53 , A61P31/18
-
公开(公告)号:CA2575002C
公开(公告)日:2015-01-20
申请号:CA2575002
申请日:2005-08-10
Applicant: JANSSEN PHARMACEUTICA NV
Inventor: HOORNAERT GEORGES JOSEPH CORNELIUS , KILONDA AMURI , HEERES JAN , LEWI PAULUS JOANNES , DE JONGE MARC RENE , DAEYAERT FREDERIK FRANS DESIRE , VINKERS HENDRIK MAARTEN , KOYMANS LUCIEN MARIA HENRICUS , JANSSEN PAUL ADRIAAN JAN
IPC: C07D253/06 , A61K31/53 , A61P31/18
Abstract: The present invention relates to HIV replication inhibitors of formula (I) a N-oxide, a pharmaceutically acceptable addition salt, a quaternary amine or a stereochemically isomeric form thereof, wherein ring A and ring B represent phenyl, pyridyl, pyridazinyl, pyrimidinyl or pyrazinyl; n and m are 1 to 4; R1 represents hydrogen; aryl; formyl; C1-6alkylcarbonyl; C1-6alkyloxycarbonyl; optionally substituted C1-6alkyl; C1-6alkyloxy C1-6alkylcarbonyl substituted with C1-6alkyloxycarbonyl; their use as a medicine, their use for the manufacture of a medicament for the treatment or the prevention of HIV infection; their processes for preparation and pharmaceutical compositions comprising them.
-
公开(公告)号:ES2442857T3
公开(公告)日:2014-02-13
申请号:ES05772015
申请日:2005-08-10
Applicant: JANSSEN PHARMACEUTICA NV
Inventor: HOORNAERT GEORGES J C , KILONDA AMURI , HEERES JAN , LEWI PAULUS JOANNES , DE JONGE MARC RENE , DAEYAERT FREDERIK F D , VINKERS HENDRIK MAARTEN , KOYMANS LUCIEN MARIA H , JANSSEN PAUL ADRIAAN JAN
IPC: C07D253/06 , A61K31/53 , A61P31/18
Abstract: Un compuesto de fórmula **Fórmula** ó un N-óxido, una sal de adición farmacéuticamente aceptable o una forma estereoquímicamente isómera de la misma, enla que: el anillo A representa fenilo; el anillo B representa fenilo; n es 1, 2, 3 o 4; m es 1, 2, 3 o 4; R1 representa hidrógeno; arilo; formilo; alquilcarbonilo C1-6; alquiloxicarbonilo C1-6; alquilo C1-6 opcionalmente sustituidocon R5; o alquiloxi C1-6alquilcarbonilo C1-6 sustituido con alquiloxicarbonilo C1-6; cada R2 independientemente representa hidrógeno; hidroxi; halo; alquilo C1-6 opcionalmente sustituido con uno o mássustituyentes cada uno independientemente seleccionado de halo, ciano, hidroxi o -C(>=O)R6; alquenilo C2-6opcionalmente sustituido con uno o más sustituyentes cada uno independientemente seleccionado de halo, ciano,hidroxi o -C(>=O)R6; alquinilo C2-6 opcionalmente sustituido con uno o más sustituyentes cada uno independientementeseleccionado de halo, ciano, hidroxi o -C(>=O)R6 ; cicloalquilo C3-7; alquiloxi C1-6; alquiloxicarbonilo C1-6; alquilcarboniloxiC1-6; carboxilo; ciano; nitro; amino; mono- o di(alquil C1-6)amino; polihaloalquilo C1-4alquilo; polihaloalquiloxi C1-4;polihaloalquiltioC1-4; -S(>=O)pR6; -NH-S(>=O)pR6; -C(>=O)R6; -NHC(>=O)H; -C(>=O)NHNH2; NHC(>=O)R6; C(>=NH)R6; o R7;R2a representa ciano; aminocarbonilo; amino; halo; NHR13; NR13R14; -C(>=O)-NHR13; -C(>=O)-NR13R14; -C(>=O)-R15; -CH>=N-NH-C(>=O)-R16; alquilo C1-6 opcionalmente sustituido con uno o más sustituyentes cada uno independientementeseleccionado de halo, ciano, hidroxi, NR9R10, -C(>=O)-NR9R10, -C(>=O)-alquilo C1-6, -C(>=O)-O-alquilo C1-6, -C(>=O)-polihaloalquilo C1-6, -C(>=O)-O-polihaloalquiloC1-6 o R7; alquiloxi C1-6 opcionalmente sustituido con uno o mássustituyentes cada uno independientemente seleccionado de halo, ciano, hidroxi, NR9R10, -C(>=O)-NR9R10, -C(>=O)-alquilo C1-6, -C(>=O)-O-alquilo C1-6, -C(>=O)-polihaloalquilo C1-6, -C(>=O)-O-polihaloalquilo C1-6 o R7; alquiloxi C1-6-alquiloC1-6 opcionalmente sustituido con uno o más sustituyentes cada uno independientemente seleccionado de halo, ciano,hidroxi, NR9R10, -C(>=O)-NR9R10, -C(>=O)-alquilo C1-6, -C(>=O)-O-alquilo C1-6, -C(>=O)-polihaloalquilo C1-6, -C(>=O)-OpolihaloalquiloC1-6 o R7; alquenilo C2-6 opcionalmente sustituido con uno o más sustituyentes cada uno independientemente seleccionado de halo, ciano, hidroxi, NR9R10, -C(>=O)-NR9R10, -C(>=O)-alquilo C1-6, -C(>=O)-O-alquiloC1-6, -C(>=O)-polihaloalquilo C1-6, -C(>=O)-O-polihaloalquilo C1-6 o R7; alquinilo C2-6 opcionalmente sustituido con uno omás sustituyentes cada uno independientemente seleccionado de halo, ciano, hidroxi, NR9R10, -C(>=O)-NR9R10, -C(>=O)-alquilo C1-6, -C(>=O)-O-alquilo C1-6, -C(>=O)-polihaloalquilo C1-6, -C(>=O)-O-polihaloalquilo C1-6 o R7; -C(>=N-O-R8)-alquiloC1-4; R7 o -X3-R7.
-
公开(公告)号:AT402152T
公开(公告)日:2008-08-15
申请号:AT04708367
申请日:2004-02-05
Applicant: JANSSEN PHARMACEUTICA NV
Inventor: LEWI PAULUS JOANNES , JANSSEN PAUL ADRIAAN , DE JONGE MARC RENE , KOYMANS LUCIEN MARIA HENRICUS , VINKERS HENDRIK MAARTEN , DAEYAERT FREDERIK FRANS DESIRE , HEERES JAN , LEENDERS RUBEN GERARDUS GEORGE , HOORNAERT GEORGES JOSEPH CORNE , KILONDA AMURI , LUDOVICI DONALD W
IPC: C07D253/06 , A61K31/53 , C07D253/07 , C07D253/075
Abstract: The present invention relates to HIV replication inhibitors of formula (I) as defined in the specification their use as a medicine, their processes for preparation and pharmaceutical compositions comprising them.
-
公开(公告)号:PL232814B1
公开(公告)日:2019-07-31
申请号:PL37810704
申请日:2004-02-05
Applicant: JANSSEN PHARMACEUTICA NV
Inventor: LEWI PAULUS JOANNES , JANSSEN PAUL ADRIAN JAN , DE JONGE MARC RENÉ , KOYMANS LUCIEN MARIA HENRICUS , VINKERS HENDRIK MAARTEN , DAEYAERT FREDERIK FRANS DESIRÉ , HEERES JAN , LEENDERS RUBEN GERARDUS GEORGE , HOORNAERT GEORGES JOSEPH CORNELIUS , KILONDA AMURI , LUDOVICI DONALD WILLIAM
IPC: C07D253/075 , A61K31/53 , A61P31/18 , C07D253/06 , C07D253/07
-
公开(公告)号:AU2004213173B2
公开(公告)日:2010-07-29
申请号:AU2004213173
申请日:2004-02-05
Applicant: JANSSEN PHARMACEUTICA NV
Inventor: LUDOVICI DONALD WILLIAM , JANSSEN PAUL ADRIAAN JAN , LEENDERS RUBEN GERARDUS GEORGE , JONGE MARC RENE DE , HOORNAERT GEORGES JOSEPH CORNELIUS , HEERES JAN , KILONDA AMURI , VINKERS HENDRIK MAARTEN , LEWI PAULUS JOANNES , KOYMANS LUCIEN MARIA HENRICUS , DAEYAERT FREDERIK FRANS DESIRE
IPC: C07D253/07 , A61K31/53 , C07D253/06 , C07D253/075
Abstract: The present invention relates to HIV replication inhibitors of formula (I) as defined in the specification their use as a medicine, their processes for preparation and pharmaceutical compositions comprising them.
-
-
-
-
-
-
-
-
-